Artificial intelligence-based health tech start-up NIRAMAI Health Analytix has closed $6 million in a Series A round of funding, led by Dream Incubator, a Japanese VC firm, with participation from BEENEXT and other investors.
“Earlier investors pi Ventures, Ankur Capital, Axilor Ventures and Binny Bansal also participated in the round. The funds will be used for scaling up in India, hiring top talent and getting additional regulatory approvals for international expansion,” said a company statement. Founded in July 2016 by Geetha Manjunath and Nidhi Mathur, NIRAMAI has previously raised a seed round of $1mn in April 2017.
Dr. Geetha Manjunath, CEO & CTO of NIRAMAI, said: “NIRAMAI helps to bridge the gap in our healthcare delivery systems by providing an AI tool that is accurate, affordable and accessible to all. If institutionalised as regular screening method, NIRAMAI Thermalytix has the potential to save many lives not just from breast cancer deaths but eventually other diseases as well. We are thankful to the continued support and mentorship provided by our seed investors and are excited to join hands with our new investors to propel us to next level of growth.”